Cited by 33Nicotinic Acetylcholine Receptors StudySmoking Behavior and CessationNeurotransmitter Receptor Influence on Behavior

The role of various nicotinic receptor subunits and factors influencing nicotine conditioned place aversion

Open access
Jackson, K.J., Kota, D.H., Martin, B.R., Damaj, M.I.·2009·Neuropharmacology

Abstract

Affective nicotine withdrawal symptoms are of major motivational significance in contributing to relapse and continued tobacco use; thus, it is important to understand the molecular and receptor-mediated mechanisms that mediate affective withdrawal behaviors. Previous work using the conditioned place aversion (CPA) model has shown that nicotine withdrawal is associated with a negative affective state, and place aversion to previously neutral environmental stimuli represents a motivational component in the maintenance of drug use. Thus, the purpose of this study was to evaluate the role of genotype, sex, and age and to extend previous studies examining the role of various nicotinic receptor subtypes in the development of nicotine withdrawal aversion using the CPA model. Mice were chronically treated with nicotine and conditioned for two days with various nicotinic receptor antagonists. The major findings showed that mecamylamine and dihydro-beta-erythroidine (DHbetaE), but not hexamethonium or methyllycaconitine citrate (MLA), precipitated significant aversion in the CPA model. This pharmacological data support our previous knockout mouse data suggesting that nicotine CPA is mediated by central beta2-containing nicotinic receptors, but not alpha7 nicotinic receptors. Further, we show that sex and age are contributing factors to the development of nicotine CPA. Overall, the results of our study provide some insight into pharmacological and behavioral factors involved in the development of an aversive motivational component associated with nicotine withdrawal.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.neuropharm.2009.01.023

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • β2-containing and α6-containing nAChRs are necessary for conditioned place aversion, but α5 and α7 do not affect it.

    “Pharmacological studies in nAChR null mice indicate that β2-containing and α6-containing nAChRs are necessary for CPA, but neither the α5, nor the α7 subunits affect CPA behavior [170, 172, 189].”

    From Mechanistic insights into nicotine withdrawal (2011) · cites this paper as [189]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Jackson, K. J., Kota, D. H., Martin, B. R., & Damaj, M. I.
Affiliations
Virginia Commonwealth University (US)
Corresponding author
Jackson, K.J.
Venue
Neuropharmacology
Publisher
Elsevier BV
Published
2009-05
Volume
56
Issue
6-7
Pages
970-974
ISSN
0028-3908 (ISSN-L)
OpenAlex
W2012738237
Cited by
33
References
2
Citations by year
2025: 1 · 2021: 3 · 2020: 2 · 2019: 2 · 2018: 2 · 2016: 1 · 2015: 6 · 2014: 2 · 2013: 4 · 2012: 4
FWCI
1.34
Type
journal article
Language
en
Open access
Locations
  • Neuropharmacology (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Institute on Drug Abuse (R01DA012610, DA 05274, DA-12610, P50DA005274)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
  • Health Sciences › Medicine › Physiology › Smoking Behavior and Cessation
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Keywords
nicotine withdrawal, conditioned place aversion, nicotinic acetylcholine receptors, alpha7 nicotinic acetylcholine receptor, mecamylamine, dihydro-beta-erythroidine, hexamethonium, methyllycaconitine, sex differences, age effects, genotypes, negative affect
MeSH terms
Age Factors, Animals, Avoidance Learning, Conditioning, Psychological, Female, Male, Nicotine, Receptors, Nicotinic, Sex Factors, Species Specificity, Substance Withdrawal Syndrome, Nicotinic Antagonists, Protein Subunits, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review